NO158673C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.

Info

Publication number
NO158673C
NO158673C NO843377A NO843377A NO158673C NO 158673 C NO158673 C NO 158673C NO 843377 A NO843377 A NO 843377A NO 843377 A NO843377 A NO 843377A NO 158673 C NO158673 C NO 158673C
Authority
NO
Norway
Prior art keywords
azurend
derivatives
preparation
therapeutically active
analogy procedure
Prior art date
Application number
NO843377A
Other languages
English (en)
Norwegian (no)
Other versions
NO843377L (no
NO158673B (no
Inventor
Kahei Takase
Masafumi Yasunami
Tsuyoshi Tomiyama
Akira Tomiyama
Takashi Yanagisawa
Original Assignee
Kotobuki Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP15318783A external-priority patent/JPS6048960A/ja
Priority claimed from JP1402884A external-priority patent/JPS60158160A/ja
Application filed by Kotobuki Seiyaku Co Ltd filed Critical Kotobuki Seiyaku Co Ltd
Publication of NO843377L publication Critical patent/NO843377L/no
Publication of NO158673B publication Critical patent/NO158673B/no
Publication of NO158673C publication Critical patent/NO158673C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/47—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton having at least one of the sulfo groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO843377A 1983-08-24 1984-08-23 Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater. NO158673C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15318783A JPS6048960A (ja) 1983-08-24 1983-08-24 アズレン誘導体及びその製法並びにこの化合物を有効成分とする抗潰瘍剤
JP1402884A JPS60158160A (ja) 1984-01-28 1984-01-28 アズレン誘導体スルホン酸塩、抗潰瘍、抗炎症剤及びその製法

Publications (3)

Publication Number Publication Date
NO843377L NO843377L (no) 1985-02-25
NO158673B NO158673B (no) 1988-07-11
NO158673C true NO158673C (no) 1988-10-19

Family

ID=26349908

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843377A NO158673C (no) 1983-08-24 1984-08-23 Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.

Country Status (13)

Country Link
US (1) US4595694A (es)
EP (1) EP0147915B1 (es)
KR (1) KR920000956B1 (es)
AR (1) AR240554A1 (es)
AU (1) AU571554B2 (es)
CA (1) CA1228862A (es)
DE (1) DE3463502D1 (es)
DK (1) DK169870B1 (es)
ES (1) ES8506607A1 (es)
HU (1) HU195478B (es)
NO (1) NO158673C (es)
PT (1) PT79119B (es)
SU (1) SU1311618A3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081152A (en) * 1989-07-05 1992-01-14 Kotobuki Seiyaku Co., Ltd. Azulene derivatives as thromboxane a2 and prostaglandin endoperoxide receptor antagonist
EP0887077A1 (de) * 1997-06-27 1998-12-30 Roche Diagnostics GmbH Verwendung von Azulenderivaten als Metalloproteaseinhibitoren
US6420435B1 (en) 1999-11-01 2002-07-16 Joe S. Wilkins, Jr. Method for treating gastrointestinal disorders
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
US7041706B2 (en) * 2002-04-19 2006-05-09 Wilkins Jr Joe S Method for treating crohn's disease
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227896B (de) * 1965-12-02 1966-11-03 Degussa Verfahren zur Herstellung wasserloeslicher stabiler Salze von Azulensulfonsaeureamiden
US3816612A (en) * 1967-03-23 1974-06-11 Degussa Process for the production of basically reacting pharmaceuticals
US3974299A (en) * 1974-07-08 1976-08-10 Dynapol Ionic sweetener
US4224240A (en) * 1979-04-13 1980-09-23 Scm Corporation Preparation of para-menth-1-ene-7-sulfonate salts and corresponding acids
US4283347A (en) * 1979-04-13 1981-08-11 Scm Corporation Para-menth-1-ene-7-sulfonic acid and salts thereof

Also Published As

Publication number Publication date
DE3463502D1 (en) 1987-06-11
KR920000956B1 (ko) 1992-01-31
NO843377L (no) 1985-02-25
PT79119A (en) 1984-09-01
ES535381A0 (es) 1985-07-16
DK377984D0 (da) 1984-08-03
KR850001731A (ko) 1985-04-01
EP0147915A1 (en) 1985-07-10
EP0147915B1 (en) 1987-05-06
HUT37393A (en) 1985-12-28
SU1311618A3 (ru) 1987-05-15
HU195478B (en) 1988-05-30
AU3139684A (en) 1985-02-28
ES8506607A1 (es) 1985-07-16
CA1228862A (en) 1987-11-03
PT79119B (en) 1986-07-17
NO158673B (no) 1988-07-11
AR240554A1 (es) 1990-05-31
US4595694A (en) 1986-06-17
DK169870B1 (da) 1995-03-20
DK377984A (da) 1985-02-25
AU571554B2 (en) 1988-04-21

Similar Documents

Publication Publication Date Title
NO161372C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive guaninderivater.
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO164415C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO156865C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO158376C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme rooperolforbindelser.
NO157934C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider.